News
Actelion shares gain on report of progress in Sanofi talks
December 21, 2016 by publisher · Leave a Comment
Swiss biotech group Actelion's shares rose by more than 3 percent on Wednesday following a report that talks with Sanofi are making progress, increasing optimism that the two will strike a deal. Analysts at Basler Kantonalbank and Thurguaer Kantonalbank
Originally posted here:
Actelion shares gain on report of progress in Sanofi talks